Breaking News Instant updates and real-time market news.

AVXS

AveXis

$211.85

0.68 (0.32%)

, NVS

Novartis

$80.91

-0.96 (-1.17%)

07:34
04/12/18
04/12
07:34
04/12/18
07:34

AveXis downgraded to Equal Weight from Overweight at Barclays

Barclays analyst Gena Wang downgraded AveXis (AVXS) to Equal Weight to reflect the proposed takeover by Novartis (NVS). The analyst sees limited antitrust risks and a low probability of a counterbid. She raised her price target for AveXis shares to $218 from $152. She believes the price being paid by Novartis fully reflects the value of the stock.

AVXS

AveXis

$211.85

0.68 (0.32%)

NVS

Novartis

$80.91

-0.96 (-1.17%)

  • 23

    Apr

  • 17

    May

  • 05

    Jun

AVXS AveXis
$211.85

0.68 (0.32%)

04/10/18
JEFF
04/10/18
NO CHANGE
JEFF
Jefferies sees value in Abeona, Sangamo, Ultragenyx after AveXis deal
Jefferies analyst Maury Raycroft believes Novartis' (NVS) acquisition of AveXis (AVXS) provides additional validation for the progress and potential of gene therapy. The deal brings attention to Abeona Therapeutics (ABEO) specifically, based on the company's use of AAV9, which is the same vector AveXis has been evaluating with its lead program AVXS-101, Raycroft tells investors in a research note. He thinks yesterday's takeover puts an updated value on gene therapy, implying long-term potential and "sufficient de-risking has occurred." The analyst feels the premium paid for AveXis shows value in Abeona, Sangamo (SGMO) and Ultragenyx (RARE).
04/10/18
SBSH
04/10/18
DOWNGRADE
SBSH
Neutral
AveXis downgraded to Neutral from Buy at Citi
CIit analyst Mohit Bansa downgraded AveXis (AVXS) following the company's agreement to be acquired by Novartis (NVS). The analyst in late January called AveXis an "interesting" takeover target. His buyout valuation was $185 per share without extra credit to the pipeline and $250 per share when including a 25% probability to Rhett and 25% extra probability to spinal muscular atrophy type 2. Novartis is buying the company for $218 per share or $8.7B in cash.
04/11/18
FBCO
04/11/18
DOWNGRADE
Target $218
FBCO
Neutral
AveXis downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Martin Auster downgraded AveXis (AVXS) to Neutral from Outperform and raised his price target on the shares to $218 from $170 ahead of likely closing of the Novartis (NVS) deal.
04/12/18
UBSW
04/12/18
DOWNGRADE
Target $218
UBSW
Neutral
AveXis downgraded to Neutral from Buy at UBS
UBS analyst Carter Gould downgraded AveXis (AVXS) to Neutral while raising his price target for the shares to $218 from $143. The analyst has confidence the takeover by Novartis (NVS) will close, and notes the shares are within 5% of the $218 offer price. The chance of antitrust concerns arising are remote, Gould tells investors in a research note.
NVS Novartis
$80.91

-0.96 (-1.17%)

04/10/18
BERN
04/10/18
NO CHANGE
Target $318
BERN
Outperform
Acquisition of AveXis increases pressure on Biogen Spinraza, says Bernstein
Bernstein analyst Aaron Gal believes that Biogen (BIIB) odds of counter-bidding Novartis (NVS) takeout offer for AveXis (AVXS) are low, primarily because of FTC concerns. Nonetheless, the analyst notes that this increases pressure on Biogen's Spinraza as it puts the competing SMA program in the hands of a well-funded, payer-competent, global-reaching company. Gal reiterates an Outperform rating and $318 price target on Biogen's shares.

TODAY'S FREE FLY STORIES

EXEL

Exelixis

$19.90

0.26 (1.32%)

11:10
08/14/18
08/14
11:10
08/14/18
11:10
Conference/Events
Exelixis management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 14

    Jan

ECL

Ecolab

$147.03

1.08 (0.74%)

11:07
08/14/18
08/14
11:07
08/14/18
11:07
Conference/Events
Ecolab management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 16

    Aug

  • 05

    Sep

  • 11

    Sep

GE

General Electric

$12.49

0.05 (0.40%)

11:00
08/14/18
08/14
11:00
08/14/18
11:00
Options
GE Bear lays out $1.68M for 66day downside spread »

GE Bear lays out $1.68M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

11:00
08/14/18
08/14
11:00
08/14/18
11:00
General news
Treasury Option Action: light call positioning on the 10-year »

Treasury Option Action:…

SYPR

Sypris Solutions

$1.67

0.09 (5.70%)

10:58
08/14/18
08/14
10:58
08/14/18
10:58
Earnings
Sypris Solutions confirms 2H guidance for revenue of $47M-$51M »

The company confirmed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

SYPR

Sypris Solutions

$1.67

0.09 (5.70%)

10:57
08/14/18
08/14
10:57
08/14/18
10:57
Earnings
Sypris Solutions reports Q2 EPS 4c, one estimate 0c »

Reports Q2 revenue $23M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

AMD

AMD

$20.18

0.46 (2.33%)

10:50
08/14/18
08/14
10:50
08/14/18
10:50
Options
In-the-money vertical call spread sale in AMD with shares at 10 year highs »

In-the-money vertical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 12

    Sep

10:50
08/14/18
08/14
10:50
08/14/18
10:50
General news
Treasury Action: curve flatteners have returned »

Treasury Action: curve…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.16

1.03 (0.37%)

10:40
08/14/18
08/14
10:40
08/14/18
10:40
Technical Analysis
Technical Take: SPDR S&P 500 ETF hits session highs after first hour »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.16

1.03 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$82.35

0.49 (0.60%)

10:40
08/14/18
08/14
10:40
08/14/18
10:40
Options
Second day of active trading in Phillip Morris calls as shares tick higher »

Second day of active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EA

Electronic Arts

$130.53

-0.76 (-0.58%)

10:33
08/14/18
08/14
10:33
08/14/18
10:33
Hot Stocks
Electronic Arts announces departure of Chief Design Officer Patrick Soderlund »

Electronic Arts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 04

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

CSCO

Cisco

$43.74

-0.02 (-0.05%)

10:30
08/14/18
08/14
10:30
08/14/18
10:30
Options
Short-term call spreads in Cisco ahead of earnings »

Short-term call spreads…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 29

    Aug

  • 30

    Aug

  • 04

    Sep

  • 12

    Sep

10:30
08/14/18
08/14
10:30
08/14/18
10:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

EEFT

Euronet

$94.17

0.29 (0.31%)

10:27
08/14/18
08/14
10:27
08/14/18
10:27
Conference/Events
Euronet management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 21

    Aug

  • 04

    Sep

  • 12

    Sep

VIPS

Vipshop

$7.79

-1.19 (-13.25%)

10:24
08/14/18
08/14
10:24
08/14/18
10:24
Downgrade
Vipshop rating change  »

Vipshop downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 10

    Sep

ARDS

Aridis Pharmaceuticals

$0.00

(0.00%)

10:22
08/14/18
08/14
10:22
08/14/18
10:22
Syndicate
Breaking Syndicate news story on Aridis Pharmaceuticals »

Aridis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

NLSN

Nielsen

$25.87

1.25 (5.08%)

10:22
08/14/18
08/14
10:22
08/14/18
10:22
Hot Stocks
Analysts up Nielsen rating as Elliott takes activist stake, plans push for sale »

After jumping yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$180.13

-0.21 (-0.12%)

10:20
08/14/18
08/14
10:20
08/14/18
10:20
Options
Bearish vertical put spread in Triple Qs may roll protection »

Bearish vertical put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$46.01

0.19 (0.41%)

, PEP

PepsiCo

$112.91

-0.11 (-0.10%)

10:17
08/14/18
08/14
10:17
08/14/18
10:17
Recommendations
Coca-Cola, PepsiCo, Keurig Dr Pepper analyst commentary  »

BodyArmor stake positive…

KO

Coca-Cola

$46.01

0.19 (0.41%)

PEP

PepsiCo

$112.91

-0.11 (-0.10%)

KDP

Keurig Dr Pepper

$23.51

-0.24 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/14/18
08/14
10:17
08/14/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/14/18
08/14
10:16
08/14/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBM

Hudbay Minerals

$4.93

-0.1 (-1.99%)

, ESTA

Establishment Labs

$27.10

(0.00%)

10:16
08/14/18
08/14
10:16
08/14/18
10:16
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

HBM

Hudbay Minerals

$4.93

-0.1 (-1.99%)

ESTA

Establishment Labs

$27.10

(0.00%)

YEXT

Yext

$22.84

0.27 (1.20%)

AKBA

Akebia

$8.22

0.4 (5.12%)

REPL

Replimune Group

$17.10

0.01 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 16

    Aug

CB

Chubb

$133.41

-1.56 (-1.16%)

, SWCH

Switch

$10.24

-3.72 (-26.65%)

10:16
08/14/18
08/14
10:16
08/14/18
10:16
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

CB

Chubb

$133.41

-1.56 (-1.16%)

SWCH

Switch

$10.24

-3.72 (-26.65%)

URBN

Urban Outfitters

$47.09

-0.33 (-0.70%)

PINC

Premier

$37.46

-0.99 (-2.57%)

PH

Parker-Hannifin

$166.69

-0.555 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 14

    Sep

CMC

Commercial Metals

$22.26

0.46 (2.11%)

, NLSN

Nielsen

$25.83

1.21 (4.91%)

10:16
08/14/18
08/14
10:16
08/14/18
10:16
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

CMC

Commercial Metals

$22.26

0.46 (2.11%)

NLSN

Nielsen

$25.83

1.21 (4.91%)

ADS

Alliance Data

$231.12

3.785 (1.66%)

DCP

DCP Midstream

$44.67

0.1 (0.22%)

JKS

JinkoSolar

$13.33

-0.57 (-4.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 11

    Sep

  • 12

    Sep

  • 06

    Nov

MGM

MGM Resorts

$29.00

-0.03 (-0.10%)

10:10
08/14/18
08/14
10:10
08/14/18
10:10
Options
MGM calls active Tuesday after bullish risk-reversals opened Monday »

MGM calls active Tuesday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.